Evidence map›Paper›PMID 40282524›Full record

ArticleCancers2025

HERmione: Understanding the Needs of Patients Living with Metastatic HER2-Positive Breast Cancer Through a Cross-Sectional Survey in Parallel with Patients and Oncologists.

Gilles Freyer, Caroline Rigault, Laure Guéroult Accolas, Anthony Barea, Narcisa Radu, Assia Ouamer, Mahasti Saghatchian

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gilles FreyerCHU Lyon-Sud, Institut de Cancérologie et Université de Lyon, 69002 Lyon, France.
Caroline RigaultCHRU Tours, 37000 Tours, France.
Laure Guéroult AccolasMon Réseau Cancer du Sein, 75006 Paris, France.
Anthony BareaWefight, 75013 Paris, France.
Narcisa RaduSeagen, 92500 Rueil-Malmaison, France.
Assia OuamerPfizer, 75014 Paris, France.
Mahasti SaghatchianHôpital Américain de Paris, Neuilly sur Seine, 92200 Neuilly-sur-Seine, France.

Funding

Seagen N/A
6 · The paper itself

Abstract

BACKGROUND/

objectivesHER2-positive metastatic breast cancer continues to have a significant impact on patients' lives. The HERmione project was conducted in France to identify patients' needs for support and information, understand services offered, and identify differences in the perception of burden between patients and oncologists.

methodsBetween July and October 2022, 273 patients with HER2-positive metastatic breast cancer and 40 oncologists were surveyed. The mean age of patients was 52 years, with most receiving treatment at specialized cancer centers (38%) or other public hospitals (34%).

resultsThe survey revealed a substantial burden of the disease and treatment in patients, perceptions that differed from those of oncologists. Both the physical and mental well-being of the patients were below average. Despite the burden of the disease, patients lacked access to many types of support, particularly support with sexual well-being. Additionally, 60% of patients did not have access to nursing support. Patients had high expectations regarding access to information but often did not know where to access this information. Despite this, they still exhibited treatment preferences.

conclusionsThese findings suggest that enhanced communication is critical to ensure that patients receive adequate support. Nursing support could improve patient-oncologist communication and thereby enhance patient well-being. Finally, to meet patient expectations regarding information access, a broader array of support tools should be offered.

Indexed as

breast cancerclinician-reported outcomesoncologypatient-reported outcomesquality of lifesupport needstreatment preferences

Identifiers

PMID40282524
PMCPMC12025477

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.